Brandon possesses over 8 years of focused expertise in specialty pharmaceuticals, particularly ultra-orphan, orphan and rare disease where he has successfully managed specialty programs and products, from clinical trial to commercialization for major bio-pharmaceutical partners, contributing to overall business growth. Additionally, Brandon played an instrumental role in designing and executing Optime Care’s patient-first approach, a unique specialty drug management strategy to improve health outcomes and optimize the overall experience for patients with rare and orphan diseases and chronic complex conditions.
Prior to joining Optime Care, Brandon served as a team pharmacist for Dohmen Life Science Services, where he helped launch several new care programs and assisted in the management of clinical trial activities. Dr. Salke has been involved in all aspects of operations (planning, process integration, project management, etc.) for pharmaceutical manufacturers. This includes clinical trials to commercialization and assisting in commercial launches (and relaunch) of specialty pharmaceuticals.
Dr. Salke completed his PharmD from St. Louis College of Pharmacy (StLCOP) in St. Louis, MO and holds the Certified Specialty Pharmacist (CSP) credential from the National Association of Specialty Pharmacy. He is currently an active member of the National Association of Specialty Pharmacy (NASP) and the Missouri Pharmacists Association (MPA). Dr. Salke currently holds a pharmacist license in 22 states and the US Territory, Guam, allowing him a deep understanding of state and federal pharmacy.
As an active clinician and researcher, Dr. Salke has contributed to studies on different therapies for rare and orphan diseases as well as co-authored publications. Most recently, he has been chosen finalist and nominated for several awards.